New Pediatric Labeling Information Database - Detail

Please note: JavaScript must be enabled for this application to work properly.
Check your settings if you are unsure
if your JavaScript is enabled.

Pediatric Labeling Date:

11/08/2012

Trade Name:

VIRAMUNE XR

Generic Name or Proper Name (*):

nevirapine

Indications Studied:

Treatment of HIV-1 infection

Label Changes Summary:

* Approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in children 6 - < 18 years. Use in pediatric patients 6 - < 18 years is based on pharmacokinetic, safety, and antiviral activity data from an open-label trial and supported by previous demonstration of efficacy in adults. * Not recommended for children < 6 years since clinical trial did not provide sufficient pharmacokinetic data for children 3 - < 6 years to support the use in this age group. Furthermore, not recommended for children < 3 years because they are not able to swallow tablets. * Viramune XR tablets must be swallowed whole and must not be chewed, crushed, or divided. * Children should be assessed for their ability to swallow tablets before prescribing * No recommendations can be made regarding substitution of four VIRAMUNE XR 100 mg tablets for one VIRAMUNE XR 400 mg tablet * Pediatric patients may be dosed using Viramune XR 400 mg or 100 mg tablets. Viramune XR is dosed based on a patients body surface area (BSA). All pediatric patients must initiate therapy with immediate-release Viramune at a dose not to exceed 200 mg per day, administered once daily for the first 14 days because it has been demonstrated to reduce the frequency of rash. This lead-in period is not required if the patient is already on a regimen of twice daily immediate-release formulation * Adverse reactions were similar to those observed in adults. In pediatric patients the incidence of Grade 2 or higher drug-related rash was 1%Information on recommended dosing based on BSA, pharmacokinetics, adverse reactions, and clinical trial * Postmarketing study